Related Experiment Video

Updated: Feb 6, 2026

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

7.9K

Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major

Chi Kong Li1, Paul K S Chan, Siu Cheung Ling

  • 1Departments of Paediatrics and Microbiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR, China. ckli@cuhk.edu.hk

British Journal of Haematology
|May 25, 2002
PubMed

Insights

Hepatitis C virus (HCV) treatment in thalassaemia patients showed a 72.2% sustained response rate. Combination therapy with interferon alpha and ribavirin was effective, though it temporarily increased blood consumption due to haemolysis.

Area of Science:

  • Hepatology
  • Virology
  • Hematology

Background:

  • Hepatitis C virus (HCV) is frequently observed in patients with transfusion-dependent thalassaemia.
  • Standard treatment protocols for HCV may require adjustments in this patient population.

Purpose of the Study:

  • To evaluate the clinical effectiveness of a 12-month combination therapy for HCV in previously untreated thalassaemia patients.
  • To assess sustained virological and biochemical responses post-treatment.

Main Methods:

  • A cohort of 18 transfusion-dependent thalassaemia patients received 12-month treatment with interferon alpha and oral ribavirin.
  • Patients were assessed for sustained response 6 months after completing therapy.
  • Viral genotypes (1b and 6a) and treatment-related side effects were recorded.

Main Results:

  • A sustained biochemical and virological response rate of 72.2% was achieved 6 months post-treatment.
  • The majority of patients (14/18) were infected with HCV genotype 1b.
  • Ribavirin-induced haemolysis led to a temporary 30% increase in blood consumption.

Conclusions:

  • Combination therapy of interferon alpha and ribavirin demonstrates high efficacy in treating HCV in thalassaemia patients.
  • Sustained response rates are promising even with genotype 1b infections.
  • Careful monitoring for haemolysis and potential blood transfusions is necessary during treatment.

More Related Videos

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses10:10

Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses

Published on: November 16, 2016

14.3K
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

23.9K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Anatomy of the Brain: Major Regions01:20

Anatomy of the Brain: Major Regions

The brain is the most complex organ in the human body. It consists of four main parts: the cerebrum, diencephalon, cerebellum, and brainstem.
The cerebrum is the largest section of the brain and divides into left and right hemispheres, separated by a deep fissure. The cerebral outer layer of grey matter — the cerebral cortex — comprises elevations called gyri and shallow groves called sulci. The inner portion of white matter includes long nerve fibers known as axons, which connect...
10.5K
Major Organs of the Digestive System01:19

Major Organs of the Digestive System

The digestive system is responsible for the ingestion of food, secretion of enzymes, mixing and digesting food, absorption of the nutrients and defecation. The human digestive system consists of two major parts: the gastrointestinal tract and the accessory digestive organs.
Gastrointestinal tract:
9.7K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
2.0K
Major Losses in Pipes01:28

Major Losses in Pipes

When a fluid flows through a pipe, it experiences energy losses due to frictional resistance along the pipe walls, known as major losses. These energy losses result in a pressure drop, which varies based on the flow conditions — whether laminar or turbulent — and the specific physical properties of the fluid and pipe.
Fluid flow can be classified as laminar or turbulent, primarily based on the Reynolds number. This dimensionless number reflects the relative influence of inertial to viscous...
2.0K
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
6.0K